Industry Press Release

The American Epilepsy Society's Industry Press Releases page provides news from the industry as a courtesy to site visitors. Information contained within these documents has not been peer reviewed nor is it endorsed by the American Epilepsy Society.

Questions regarding these releases should be directed to information sources listed in the releases. 

New release - November 14, 2008 - Eisai FDA Approves BANZEL™ (rufinamide) as Adjunctive Treatment for Severe Epilepsy Disorder

New release - October 29, 2008 - UCB’s Vimpat® approved by U.S. FDA as adjunctive therapy for partial onset seizures in adults

 New release - September 15, 2008 -Keppra XR™ approved in the U.S.

 

Archived information is currently being updated